BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32604402)

  • 1. Signature-based approaches for informed drug repurposing: targeting CNS disorders.
    Shukla R; Henkel ND; Alganem K; Hamoud AR; Reigle J; Alnafisah RS; Eby HM; Imami AS; Creeden JF; Miruzzi SA; Meller J; Mccullumsmith RE
    Neuropsychopharmacology; 2021 Jan; 46(1):116-130. PubMed ID: 32604402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing in silico screening platforms.
    Mullins JGL
    Biochem Soc Trans; 2022 Apr; 50(2):747-758. PubMed ID: 35285479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing: Iron in the fire for older drugs.
    Sonaye HV; Sheikh RY; Doifode CA
    Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
    Hudson ML; Samudrala R
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Methods for Drug Repurposing.
    Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
    Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repurposing: progress, challenges and recommendations.
    Pushpakom S; Iorio F; Eyers PA; Escott KJ; Hopper S; Wells A; Doig A; Guilliams T; Latimer J; McNamee C; Norris A; Sanseau P; Cavalla D; Pirmohamed M
    Nat Rev Drug Discov; 2019 Jan; 18(1):41-58. PubMed ID: 30310233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
    Pulley JM; Rhoads JP; Jerome RN; Challa AP; Erreger KB; Joly MM; Lavieri RR; Perry KE; Zaleski NM; Shirey-Rice JK; Aronoff DM
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():333-352. PubMed ID: 31337270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.
    Truong TTT; Panizzutti B; Kim JH; Walder K
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Omics Strategy for Translational Bioinformatics and Rapid COVID-19 Drug Repurposing.
    Revikumar A
    OMICS; 2023 Mar; 27(3):109-115. PubMed ID: 36854133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing from the perspective of pharmaceutical companies.
    Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
    Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of computational approaches to understand cancer biology for informed drug repurposing.
    Ahmed F; Samantasinghar A; Soomro AM; Kim S; Choi KH
    J Biomed Inform; 2023 Jun; 142():104373. PubMed ID: 37120047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
    Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
    Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.